logo
Twitter
Discord
Email
logo
LifeVantage Corporation

LifeVantage Corporation

NASDAQ•LFVN
CEO: Mr. Steven R. Fife CPA
Sector: Consumer Defensive
Industry: Packaged Foods
Listing Date: 1994-04-07
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company is headquartered in Lehi, Utah.
Contact Information
3300 North Triumph Boulevard, Suite 700, Lehi, UT, 84043, United States
801-432-9000
www.lifevantage.com
Market Cap
$77.99M
P/E (TTM)
6.6
11.6
Dividend Yield
2.9%
52W High
$25.38
52W Low
$5.47
52W Range
3%
Rank26Top 13.0%
5.5
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q1 2026 Data

Revenue

$58.44M+23.78%
4-Quarter Trend

EPS

$0.28+86.67%
4-Quarter Trend

FCF

-$2.74M+194.42%
4-Quarter Trend

2026 Q1 Earnings Highlights

Key Highlights

Net Income Increased Net income reached $2.155M for the quarter, up from $1.826M in 2024, reflecting improved profitability.
Diluted EPS Rises Diluted earnings per share improved to $0.17 compared to $0.14 in the prior year period.
Tax Expense Significantly Lower Income tax expense fell to $86K from $752K, resulting in a much lower effective tax rate of 3.8%.
New Product Drives Sales MindBody GLP-1 System sales positively impacted revenue, especially in the US and Japan markets this quarter.

Risk Factors

Operating Cash Flow Deterioration Net cash used in operating activities increased to ($2.305M) versus ($583K) last year, straining liquidity.
Active Customer Base Shrinking Total active customers declined 3.9% to 73,000, and total active accounts fell 1.6% to 121,000.
Higher Commission Ratios Commissions and incentives rose to 43.5% of revenue, up from 43.0%, due to sales mix changes.
Supply Chain Execution Risk Inability to execute product launches due to supply chain pressure and integrating LoveBiome assets poses risk.

Outlook

LoveBiome Acquisition Synergy LoveBiome asset acquisition closed October 1, 2025, expected to drive global revenue growth through active accounts.
International Product Expansion Plan to refine and expand international product offerings, including the MindBody GLP-1 System, throughout fiscal 2026.
Liquidity Sufficient Forecast Management expects current cash balances and operating cash flow to satisfy requirements for at least the next 12 months.
New Market Entry Commenced operations in Iceland during September 2025, expanding international market presence beyond existing regions.

Peer Comparison

Revenue (TTM)

The Hain Celestial Group, Inc.HAIN
$1.53B
-10.1%
Skillsoft Corp.SKIL
$515.77M
-3.6%
LifeVantage CorporationLFVN
$239.76M
+22.3%

Gross Margin (Latest Quarter)

LifeVantage CorporationLFVN
81.0%
+1.1pp
Skillsoft Corp.SKIL
72.7%
-2.3pp
Acme United CorporationACU
39.1%
+0.6pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
ACU$160.91M19.87.3%20.3%
HAIN$114.11M-0.2-87.8%49.3%
SKIL$83.12M-0.6-264.6%64.2%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-4.8%
Flat Growth
4Q Net Income CAGR
10.8%
Profitability Improving
Cash Flow Stability
75%
Volatile Cash Flow

Research & Insights

Next earnings:Feb 4, 2026
|
EPS:$0.22
|
Revenue:$54.40M
Reports
All Years
  • Form 10-Q - Q1 2026

    Period End: Sep 30, 2025|Filed: Nov 4, 2025|
    Revenue: $58.44M+23.8%
    |
    EPS: $0.28+86.7%
    Beat
  • Form 10-K - FY 2025

    Period End: Jun 30, 2025|Filed: Sep 4, 2025|
    Revenue: $228.53M+14.2%
    |
    EPS: $0.80+233.3%
    Beat
  • Form 10-Q - Q3 2025

    Period End: Mar 31, 2025|Filed: May 6, 2025|
    Revenue: $58.44M+21.1%
    |
    EPS: $0.28+115.4%
    Meet
  • Form 10-Q - Q2 2025

    Period End: Dec 31, 2024|Filed: Feb 5, 2025|
    Revenue: $67.76M+31.3%
    |
    EPS: $0.21-503.8%
    Beat
  • Form 10-Q - Q1 2025

    Period End: Sep 30, 2024|Filed: Oct 29, 2024|
    Revenue: $47.21M-8.1%
    |
    EPS: $0.15+198.8%
    Miss
  • Form 10-K - FY 2024

    Period End: Jun 30, 2024|Filed: Aug 28, 2024|
    Revenue: $200.16M-6.2%
    |
    EPS: $0.24+20.0%
    Beat
  • Form 10-Q - Q3 2024

    Period End: Mar 31, 2024|Filed: May 2, 2024|
    Revenue: $48.25M-10.2%
    |
    EPS: $0.13+60.5%
    Miss
  • Form 10-Q - Q2 2024

    Period End: Dec 31, 2023|Filed: Jan 30, 2024|
    Revenue: $51.62M-3.8%
    |
    EPS: $-0.05-38.3%
    Miss